Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes

(2020) Concetta Irace et al.   DIABETES OBESITY & METABOLISM

7. Diabetes Technology: Standards of Medical Care in Diabetes—2021

(2020)   DIABETES CARE

State of Type 1 Diabetes Management and Outcomes from the T1D Exchange in 2016–2018

(2019) Nicole C. Foster et al.   Diabetes Technology & Therapeutics

First assessment of the performance of an implantable continuous glucose monitoring system through 180 days in a primarily adolescent population with type 1 diabetes

(2019) Ronnie Aronson et al.   DIABETES OBESITY & METABOLISM

A Prospective Multicenter Evaluation of the Accuracy and Safety of an Implanted Continuous Glucose Sensor: The PRECISION Study

(2019) Mark P. Christiansen et al.   Diabetes Technology & Therapeutics

Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range

(2019) Tadej Battelino et al.   DIABETES CARE

Real-World Safety of an Implantable Continuous Glucose Sensor over Multiple Cycles of Use: A Post-Market Registry Study

(2019) Dorothee Deiss et al.   Diabetes Technology & Therapeutics

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor

(2019) Patricia Sanchez et al.   Diabetes Technology & Therapeutics

A Prospective Multicenter Evaluation of the Accuracy of a Novel Implanted Continuous Glucose Sensor: PRECISE II

(2018) Mark P. Christiansen et al.   Diabetes Technology & Therapeutics

Healthcare Resource Waste Associated with Patient Nonadherence and Early Discontinuation of Traditional Continuous Glucose Monitoring in Real-World Settings: A Multicountry Analysis

(2018) Shengsheng Yu et al.   Diabetes Technology & Therapeutics

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

(2017) Marcus Lind et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections

(2017) Roy W. Beck et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Accuracy and Longevity of an Implantable Continuous Glucose Sensor in the PRECISE Study: A 180-Day, Prospective, Multicenter, Pivotal Trial

(2016) Jort Kropff et al.   DIABETES CARE

Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes

(2014) Mark Mortellaro et al.   BIOSENSORS & BIOELECTRONICS

Increasedin vivostability and functional lifetime of an implantable glucose sensor through platinum catalysis

(2012) Arthur E. Colvin et al.   JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A